Picolinic Acid in Patients with Chronic Hepatitis C Infection: A Preliminary Report

Macrophage activation seems to be a feature of chronic liver diseases. Picolinic acid (PA) as a macrophage secondary signal causes the activation of interferon-gamma- (IFN-γ-) prime macrophage and triggers cytokine-driven inflammatory reactions. The rationale for seeking increased PA formation in ch...

Full description

Saved in:
Bibliographic Details
Main Authors: Jolanta Zuwała-Jagiello, Monika Pazgan-Simon, Krzysztof Simon, Maria Warwas
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2012/762863
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566985423060992
author Jolanta Zuwała-Jagiello
Monika Pazgan-Simon
Krzysztof Simon
Maria Warwas
author_facet Jolanta Zuwała-Jagiello
Monika Pazgan-Simon
Krzysztof Simon
Maria Warwas
author_sort Jolanta Zuwała-Jagiello
collection DOAJ
description Macrophage activation seems to be a feature of chronic liver diseases. Picolinic acid (PA) as a macrophage secondary signal causes the activation of interferon-gamma- (IFN-γ-) prime macrophage and triggers cytokine-driven inflammatory reactions. The rationale for seeking increased PA formation in chronic viral hepatitis is based on the involvement of activated macrophages in chronic viral hepatitis-associated inflammation. The aim of this study was to determine serum PA levels in patients with chronic hepatitis C infection, taking into account the presence of diabetes. We assessed PA and high-sensitivity C-reactive protein (hsCRP) as a marker of inflammation in 51 patients with chronic hepatitis C infection (CHC), both with and without diabetes and 40 controls. Compared with the controls, the patients with CHC showed a significant increase in plasma concentrations of PA and hsCRP (P<0.01 and P<0.05, resp.). The values of PA and hsCRP were more elevated in patients with diabetes than without diabetes (both P<0.01). The positive relationships were between PA and hsCRP levels (P<0.05) and the presence of diabetes (P<0.001). We documented that significant elevation in serum PA levels is associated with diabetes prevalence and increased inflammatory response reflected in hsCRP levels in CHC patients.
format Article
id doaj-art-b7541fbb70624643bb576eff3c6aa3e0
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-b7541fbb70624643bb576eff3c6aa3e02025-02-03T01:02:38ZengWileyMediators of Inflammation0962-93511466-18612012-01-01201210.1155/2012/762863762863Picolinic Acid in Patients with Chronic Hepatitis C Infection: A Preliminary ReportJolanta Zuwała-Jagiello0Monika Pazgan-Simon1Krzysztof Simon2Maria Warwas3Department of Pharmaceutical Biochemistry, Wroclaw Medical University, PolandClinic of Infectious Diseases, Liver Diseases and Acquired Immune Deficiency, Wroclaw Medical University, PolandClinic of Infectious Diseases, Liver Diseases and Acquired Immune Deficiency, Wroclaw Medical University, PolandDepartment of Pharmaceutical Biochemistry, Wroclaw Medical University, PolandMacrophage activation seems to be a feature of chronic liver diseases. Picolinic acid (PA) as a macrophage secondary signal causes the activation of interferon-gamma- (IFN-γ-) prime macrophage and triggers cytokine-driven inflammatory reactions. The rationale for seeking increased PA formation in chronic viral hepatitis is based on the involvement of activated macrophages in chronic viral hepatitis-associated inflammation. The aim of this study was to determine serum PA levels in patients with chronic hepatitis C infection, taking into account the presence of diabetes. We assessed PA and high-sensitivity C-reactive protein (hsCRP) as a marker of inflammation in 51 patients with chronic hepatitis C infection (CHC), both with and without diabetes and 40 controls. Compared with the controls, the patients with CHC showed a significant increase in plasma concentrations of PA and hsCRP (P<0.01 and P<0.05, resp.). The values of PA and hsCRP were more elevated in patients with diabetes than without diabetes (both P<0.01). The positive relationships were between PA and hsCRP levels (P<0.05) and the presence of diabetes (P<0.001). We documented that significant elevation in serum PA levels is associated with diabetes prevalence and increased inflammatory response reflected in hsCRP levels in CHC patients.http://dx.doi.org/10.1155/2012/762863
spellingShingle Jolanta Zuwała-Jagiello
Monika Pazgan-Simon
Krzysztof Simon
Maria Warwas
Picolinic Acid in Patients with Chronic Hepatitis C Infection: A Preliminary Report
Mediators of Inflammation
title Picolinic Acid in Patients with Chronic Hepatitis C Infection: A Preliminary Report
title_full Picolinic Acid in Patients with Chronic Hepatitis C Infection: A Preliminary Report
title_fullStr Picolinic Acid in Patients with Chronic Hepatitis C Infection: A Preliminary Report
title_full_unstemmed Picolinic Acid in Patients with Chronic Hepatitis C Infection: A Preliminary Report
title_short Picolinic Acid in Patients with Chronic Hepatitis C Infection: A Preliminary Report
title_sort picolinic acid in patients with chronic hepatitis c infection a preliminary report
url http://dx.doi.org/10.1155/2012/762863
work_keys_str_mv AT jolantazuwałajagiello picolinicacidinpatientswithchronichepatitiscinfectionapreliminaryreport
AT monikapazgansimon picolinicacidinpatientswithchronichepatitiscinfectionapreliminaryreport
AT krzysztofsimon picolinicacidinpatientswithchronichepatitiscinfectionapreliminaryreport
AT mariawarwas picolinicacidinpatientswithchronichepatitiscinfectionapreliminaryreport